Details of the Drug

General Information of Drug (ID: DMPIQAF)

• Drug Name: KD018

Indication

Disease Entry	ICD 11	Status	REF
Liver cancer	2C12	Phase 2	[1]

• Cross-matching ID: TTD ID: D0NB9T

References

• [1] ClinicalTrials.gov (NCT00730158) A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer. U.S. National Institutes of Health.